Company Filing History:
Years Active: 2014-2017
Title: Adi Haber: Innovator in Cardiovascular and Diabetes Treatment
Introduction
Adi Haber is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of medicine, particularly in the treatment of cardiovascular diseases and diabetes. With a total of 3 patents to her name, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Adi Haber's latest patents focus on the combinations of corroles and statins. One embodiment of her invention relates to methods of treating cardiovascular disease in patients. This involves administering an effective amount of a statin or a pharmaceutically acceptable salt in combination with a transition metal complex of a corrole. Further embodiments refer to pharmaceutical compositions that include both a statin and a corrole. The corrole may have a structure where the transition metal is selected from a group that includes Mn, Fe, Ru, Co, V, Cr, and Cu.
Another significant patent addresses the treatment of diseases related to diabetes. This invention provides a method for using a transition metal complex of a corrole to treat eye and kidney diseases in diabetic patients. Additionally, it offers a way to lower serum glucose and triglyceride levels in these subjects.
Career Highlights
Adi Haber is associated with the Technion Research & Development Foundation Limited, where she continues to advance her research and innovations. Her work is characterized by a strong focus on developing effective treatments that can significantly improve patient outcomes.
Collaborations
Adi collaborates with notable colleagues, including Zeev Gross and Michael Aviram. These partnerships enhance her research capabilities and contribute to the success of her innovative projects.
Conclusion
Adi Haber's contributions to the fields of cardiovascular and diabetes treatment exemplify her dedication to medical innovation. Her patents reflect a commitment to improving health outcomes through scientific research and collaboration.